CTLA4 and cancer: Our data support this hypothesis in that the increase in autoreactive B cells following combined CTLA-4 and PD-1 blockade in patients with cancer was associated with elevated proportions of blood Tregs with decreased RGS1 expression, which favors T cell egress from the gut (30).